Cardioselective muscarinic antagonists.
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002352:Carrier Proteins / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis; D002373:Cyclic AMP Receptor Protein; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D019832:N-Methylscopolamine; D010095:Oxotremorine / Q000494:pharmacology; D010703:Phorbol Esters / Q000494:pharmacology; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000502:physiology; D011950:Receptors, Cholinergic / Q000502:physiology; D011976:Receptors, Muscarinic / Q000502:physiology*; D012602:Scopolamine Derivatives / Q000494:pharmacology
D002316:Cardiotonic Agents; D002352:Carrier Proteins; D002373:Cyclic AMP Receptor Protein; D010703:Phorbol Esters; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; D010890:Pirenzepine; D010095:Oxotremorine; D002217:Carbachol; D000242:Cyclic AMP; C048593:otenzepad; D019832:N-Methylscopolamine